secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0000721371-24-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health raises FY2024 non-GAAP EPS guidance to high end of $6.75–$7.00 on strong cash flow and $250M ASR
--------------------------------------------------------------------------------

- Updated FY2024 non-GAAP diluted EPS guidance to high end of $6.75–$7.00.
- Executed $250M accelerated share repurchase in Q2; cash flow strength drove favorability.
- Completed review of at-Home Solutions ($2.6B rev) and OptiFreight Logistics ($250M rev); will invest and develop them.
- New segment structure effective Jan 1, 2024: Pharmaceutical & Specialty Solutions, GMPD, and Other.
- Q2 Medical segment profit expected consistent with Q1, but on track for FY26 target of $650M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000005/0000721371-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000005/cah-20240109.htm
  HTML page:      https://secwatch.observer/filing/0000721371-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer